08/07/2025
6:02 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2025
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/20/2025
6:08 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
3:39 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Chan Mitchell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:44 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Truex Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:30 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KAPLAN GILLA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:35 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Goldman Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:13 PM | Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:19 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Heffernan Michael Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for AVTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Avalo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/15/2025
4:33 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
6:10 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/12/2025
6:12 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/12/2025
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
6:03 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
6:02 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/01/2025
6:00 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEF 14A | |
05/01/2025
6:02 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form DEFA14A | |
05/01/2025
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form ARS | |
04/01/2025
7:06 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Chan Mitchell (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
3:37 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KANTOFF AARON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
3:44 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Truex Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
3:30 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KAPLAN GILLA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
6:02 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2025
6:06 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/30/2025
4:43 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Sullivan Christopher Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
4:51 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
VARKI PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
4:31 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
NEIL GARRY ARTHUR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2025
4:20 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Doyle Mittie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:07 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
3:13 PM | Affinity Asset Advisors, LLC (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/05/2024
6:03 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
5:23 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G | |
11/14/2024
4:21 PM | Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
11:05 AM | Allostery Investments LP (Filed by)
Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
6:30 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
4:00 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Crutcher Patrick J (Filed by)
| Form SC 13G/A | |
11/07/2024
6:20 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Critical AI announcement set to ignite AI 2.0 (Ad) Markets are jittery. Rallies fade. Sectors rotate overnight. And the true impact of new tariffs and policy shifts hasn’t even hit the data yet.
That’s why smart traders are turning to a strategy built for exactly this kind of market—fast, simple, and designed to react to real price action, not predictions. Click here to watch how it works—and why it could give smaller traders an edge before the next big m |
11/07/2024
6:02 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:04 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:17 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
10/08/2024
6:13 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/07/2024
7:06 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
| Form SC 13G | |
09/09/2024
6:22 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2024
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2024
3:34 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G | |
08/23/2024
3:16 PM | Avalo Therapeutics, Inc. (Subject)
Avalo Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
08/14/2024
3:47 PM | Almenoff June Sherie (Reporting)
Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:36 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
KANTOFF AARON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:27 PM | Avalo Therapeutics, Inc. (Issuer)
Avalo Therapeutics (Issuer)
Truex Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:01 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:03 AM | Avalo Therapeutics, Inc. (Filer)
Avalo Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
